Availability: In StockBiological Description:Bisoprolol is a selective type β1 adrenergic receptor blocker.Target: Adrenergic ReceptorApproved: July 31, 1992Bisoprolol, on beta 1-adrenoceptor peptide induced autoimmune myocardial damage. In the animal model of autoimmune cardiomyopathy induced by active immunization of rabbits with beta 1-adrenoceptor peptide, bisoprolol was given at a dose of 3 mg/day throughout the study period. Our results showed high titer of anti-beta 1-adrenoceptor antibody in the immunized group throughout the study but not in the group receiving only bisoprolol [1]. Bisoprolol administration resulted in a significant reduction in HR reaching 60.3 +/- 1.4 bpm at VT of 500 mL (compared to 70.5 +/- 1.8 bpm with placebo, P < 0.001).="" changes="" in="" hp="" were="" also="" significant="" with="" an="" increase="" in="" hp="" reaching="" 1004.5="" +/-="" 22.2="" msec="" at="" this="" controlled="" vt="" (compared="" to="" 860.3="" +/-="" 21.5="" msec="" with="" placebo,="" p="">< 0.001)="">Toxicity: Oral, mouse: LD50 = 100 mg/kg; Skin, rabbit: LD50 = 200 mg/kg; Skin, rat: LD50 = 500 mg/kg. Symptoms of overdo...Purity: >98%Molecular formula: C₄₀H₆₆N₂O₁₂Molecular Weight: 766.96Storage Instructions: Two years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSOReferences: for more information, please visit images/AffixScientific/

Affix Scientific633克朗

CAS号：286370-15-8

成为第一个评论该产品

包装 *

尺寸

 1克$ 1650

价格：            $ 1650.00

数量：

1

库存：有存货

目录号 286370-15-8

生物学描述：

KRN633是一种有效的选择性VEGFR抑制剂。抑制人脐静脉内皮细胞中VEGFR-2的酪氨酸磷酸化（IC50 = 1.16 nmol / L）。用重组酪氨酸激酶进行的选择性分析表明，KRN633对VEGFR-1，-2和-3具有高度选择性。在无胸腺小鼠和大鼠中，KRN633在几种具有不同组织起源的体内肿瘤异种移植模型（包括肺，结肠和前列腺）中抑制肿瘤生长。KRN633还可以使一些公认的肿瘤以及那些在停止治疗后已长出的肿瘤消退。KRN633具有良好的耐受性，对动物的体重或总体健康没有明显影响。KRN633可用于治疗实体瘤和其他依赖病理性血管生成的疾病。

纯度： > 98.00％

分子式： C 2 0 H 2 1 ClN 4 O 4  

分子量： 446.90

储存说明：两年-20°C粉末，2周DMSO中4°C，DMSO中6个月-80°C